Services Overview

We act as your agent, representative, interim or mentor/coach. We can set up your company in Japan. We are dedicated to making your commercial success real!

We supply the market intelligence you need to be successful in Japan!

We connect you with the right Japanese companies within Biopharma, ATMP, CGT, Regenerative Medicine, Pharmaceuticals, Combination Devices, IVD’s, Universities and distributors. The right mix you need among: Trade Shows, KOLs, customers, partners, distributors . . .

A handshake under the Rising Sun of Japan.

Biosector = Commercialization in Japan

Preparation and reports – What you need to know!

We produce your feasibility studies and all other types of reports that you need to unlock your commercial pathway into Japan’s Pharmaceutical Industry. We help pave every step of your commercialization process.

Download for free:

You need: fast, accurate and actionable reports, feasibility studies, target lists and analysis to be able to draw up the best strategies.

We supply: just that!

By partnering with Biosector, you get the upper hand!

Market Entry: Seamless Integration and Strategic Positioning

Your success in Japan requires the following keys:

  1. Budget
  2. Cultural competence
  3. Clear goals
  4. Strategic approach
  5. Feet on the ground
  6. Long term mindset
  7. Patience
  8. Consistency


We make sure you are moving as fast as possible and that your expectations are aligned with those of your future clients and partners’ in Japan.

Market Expansion: Optimizing Your New Commercial Opportunities and Accelerating Growth

Expanding your footprint in Japan is crucial. Accelerating your growth successfully equals long-term success. You need competence and excellence: we supply! You need to optimize your new avenues for growth – we support you! We assist you in making sure of your new market segments and their strategies.

Leveraging your opportunities through our extensive industry connections is a valuable shortcut.

With Biosector, you have the advantage that only comes with exceptional professionals. Every step of the way.

About Stefan Sandström 

CEO of Biosector Ltd. Residence

Residence: Based in Metropolitan Tokyo since 2007.

Unique Perspective: Science and business.

Education: Medicine and chemical engineering.

Leadership: Successfully led multiple industrial companies as CEO.

Accreditations: Accredited business consultant via  German RKW.

Collaborations: Japanese partner to notable entities:  SPECTARIS and Kalms Consulting.

Recognitions: Appointed as an expert on conducting business in Japan by the EU-Japan Centre for Industrial Cooperation.

Track Record: Three decades of experience in international and cross-border business development, achieving first sales.

Passion: Kendo (martial art) with the rank of 6 dan.

Testimonials/Cases

Dan Spacie

CEO of MAP Patient Access, UK

”I have worked with Stefan Sandström outside of Biosector for over a year and will continue to work with him in Biosector. This is an exceptionally highly skilled partner, walking the extra mile and having made all the difference for building our traction in Japan.”

Anne-Kathrin Schmalz

Senior Manager Foreign Trade and Export Promotion

”Mr Sandström delivered an amazing seminar for our members in Sep 2021. He combined extensive specialist knowledge of the Japanese bio and laboratory market and how to bridge cultural differences. ”

Tony White

“Biosector’s business intelligence has helped me identify investment opportunities I would never have discovered. They deliver incisive analysis applying the Pareto Principle, allowing me to make fast decisions and save huge amounts of time. A great help for guiding the next steps forward.” – Tony White, founder of BioPhorum and angel investor

Blog

A conceptual illustration of an hourglass with a human brain at the top, releasing a cascade of binary code (1s and 0s) and data symbols. At the bottom red bulb, two robotic hands are analyzing and sorting this data into categories marked by red checkmarks and black cross-marks. A factory and cherry blossoms are in the background.
The biopharma world is still processing the seismic news of Isomorphic Labs’ $2.1 billion Series B funding round. Led by Thrive Capital and backed by a geopolitical coalition including Alphabet, Temasek, MGX, and the UK Sovereign AI Fund, this is the largest venture round the sector […]
Japan’s pharmaceutical pricing system is often seen as a local matter. It is discussed in terms of NHI listing, foreign price adjustment, price maintenance premiums, annual revisions, and the technical details of reimbursement. That view is becoming too narrow. The recent call from FPMAJ (Federation of […]
Business leader overlooking Japan’s pharmaceutical market landscape, with Mount Fuji, Tokyo, regulatory documents, scientific data, and a rising growth chart symbolizing quality, evidence, trust, and strategic growth.
Japan is a complex pharmaceutical market, and that is exactly why you should be here. Japan will probably win the competition as the most difficult market. Many think of Japan as the market to enter later or never, filled with unreasonably demanding regulators, conservative decision-making, complex […]
Editorial illustration showing drug discovery evolving from primitive narrow target panels, through patient risk, toward modern mass spectrometry based off-target profiling and healthier treatment outcomes.
The Easy Hurdle That Kills Programs A drug candidate can clear the standard off-target panel and still be a bad clinical bet. That is the uncomfortable truth many development teams, boards, and investors prefer not to say out loud. A 44-target or 47-target screen may show […]
Wide illustration showing Japan as an interconnected medical device market entry ecosystem, with nodes for PMDA and MHLW regulation, hospitals, reimbursement, distributors, manufacturing, digital health, and overseas investors.
Japan is no longer a market foreign medical device companies can afford to treat as “difficult but optional.” It is one of the world’s major medtech markets, with strong clinical standards, sophisticated hospitals, demanding physicians, and a healthcare system under demographic pressure. For companies with differentiated […]
A wide, clean editorial illustration of an age-friendly riverside neighborhood inspired by Hongodai in Yokohama. A couple walks two dogs along a smooth, flat, step-free promenade beside a lush river corridor with flowers, cherry trees, benches, and public space. Modern residential buildings include healthcare services, a clinic, diagnostics, pharmacy access, and a civic community hub for learning, volunteering, and care support. Nearby transit, a supermarket, pharmacy, and low-floor buses show how daily needs are placed within easy walking distance. Subtle icons for healthcare, nature, community, mobility, housing, and exercise connect the scene, presenting urban planning as a practical form of preventive healthcare.
To all the healthcare innovation leaders, urban gerontologists, and care ecosystem designers in the world: if you want to see what the future of preventative medicine and age-friendly urban design actually looks like in practice, I offer you Hongodai in Yokohama. My wife and I have […]

Please feel warmly welcome to contact us:

email: info@biosector.jp
phone: +81 80-3404-8431

Address: Yokohama Landmark Tower, 20th Floor, 2-2-1 Minatomirai, Nishi-ku, 〒220-8120,

Yokohama, JAPAN

Deliveries: Kosugaya 1-20-6-202, Sakae-ku, 〒247-0007, Yokohama, JAPAN